Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Biohaven Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BHVN
New York
8731
https://www.biohaven.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Biohaven Ltd
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
- Apr 18th, 2024 10:00 am
Biohaven Announces Proposed Public Offering of Common Shares
- Apr 17th, 2024 8:05 pm
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
- Apr 13th, 2024 1:00 pm
LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?
- Apr 4th, 2024 2:03 am
Bullish Biohaven Insiders Loaded Up On US$23.8m Of Stock
- Mar 20th, 2024 11:59 am
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
- Feb 29th, 2024 9:05 pm
A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
- Feb 18th, 2024 12:10 pm
Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
- Jan 25th, 2024 10:31 pm
Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That
- Jan 22nd, 2024 12:00 pm
Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology
- Jan 8th, 2024 12:30 pm
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2024 12:00 pm
Director Irina Antonijevic Sells 11,000 Shares of Biohaven Ltd (BHVN)
- Dec 31st, 2023 8:01 am
Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting
- Dec 1st, 2023 9:30 pm
Will Biohaven (NYSE:BHVN) Spend Its Cash Wisely?
- Nov 22nd, 2023 10:13 am
Is Biohaven Ltd. (BHVN) Outperforming Other Medical Stocks This Year?
- Nov 16th, 2023 2:40 pm
Biohaven Ltd (BHVN) Reports Q3 2023 Financial Results: Advances in Clinical Programs and Strong ...
- Nov 15th, 2023 2:15 am
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
- Nov 14th, 2023 9:05 pm
Biohaven Ltd. (BHVN) Is a Great Choice for 'Trend' Investors, Here's Why
- Nov 6th, 2023 1:50 pm
Are Medical Stocks Lagging Biohaven Ltd. (BHVN) This Year?
- Oct 31st, 2023 1:40 pm
Here's Why Momentum in Biohaven Ltd. (BHVN) Should Keep going
- Oct 19th, 2023 12:50 pm
Scroll